Programmed cell death of dendritic cells in immune regulation

Immunological Reviews

Volumn 236, Issue 1, 2010, Pages 11-27

  Chen, Min ^a   Wang, Jin ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Dendritic cells; Immune tolerance; Programmed cell death

Indexed keywords

BH3 PROTEIN; BIM PROTEIN; CD11 ANTIGEN; CD4 ANTIGEN; DEATH RECEPTOR; FAS ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; PROTEIN BCL 2; PROTEIN BCL XL; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNITY; CELL EXPANSION; CELL INTERACTION; CELL MATURATION; CELL SURVIVAL; DENDRITIC CELL; HOMEOSTASIS; IMMUNOREGULATION; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MITOCHONDRION; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; THYMOCYTE; TURNOVER TIME;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN-PRESENTING CELLS; APOPTOSIS; CELL COMMUNICATION; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 77953767101     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2010.00916.x     Document Type: Review

References (179)

1. Rathmell JC, Thompson CB. The central effectors of cell death in the immune system. Annu Rev Immunol 1999 17 : 781 828.
2. Gaudin E, Rosado M, Agenes F, McLean A, Freitas AA. B-cell homeostasis, competition, resources, and positive selection by self-antigens. Immunol Rev 2004 197 : 102 115.
3. Hildeman D, Jorgensen T, Kappler J, Marrack P. Apoptosis and the homeostatic control of immune responses. Curr Opin Immunol 2007 19 : 516 521.
4. Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol 2009 9 : 823 832.
5. Liu K, et al. In vivo analysis of dendritic cell development and homeostasis. Science 2009 324 : 392 397.
6. Becker T, et al. FOXO-dependent regulation of innate immune homeostasis. Nature 2010 463 : 369 373.
7. Lenardo M, et al. Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999 17 : 221 253.
8. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 252.
9. Steinman RM, Hemmi H. Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 2006 311 : 17 58.
10. Liu YJ. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001 106 : 259 262.
11. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003 21 : 685 711.
12. Roskrow MA, Dilloo D, Suzuki N, Zhong W, Rooney CM, Brenner MK. Autoimmune disease induced by dendritic cell immunization against leukemia. Leuk Res 1999 23 : 549 557.
13. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 1998 188 : 1493 1501.
14. Chen M, et al. Dendritic cell apoptosis in the maintenance of immune tolerance. Science 2006 311 : 1160 1164.
15. Stranges PB, et al. Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity. Immunity 2007 26 : 629 641.
16. Ohnmacht C, et al. Constitutive ablation of dendritic cells breaks self tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009 206 : 549 559.
17. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973 137 : 1142 1162.
18. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J Exp Med 1974 139 : 380 397.
19. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002 2 : 151 161.
20. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol 2007 7 : 19 30.
21. Wu L, Liu YJ. Development of dendritic-cell lineages. Immunity 2007 26 : 741 750.
22. Villadangos JA, Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007 7 : 543 555.
23. Ruedl C, Koebel P, Bachmann M, Hess M, Karjalainen K. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J Immunol 2000 165 : 4910 4916.
24. Kamath AT, et al. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 2000 165 : 6762 6770.
25. O'Keeffe M, et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med 2002 196 : 1307 1319.
26. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002 100 : 1734 1741.
27. Chen M, Huang L, Shabier Z, Wang J. Regulation of the lifespan in dendritic cell subsets. Mol Immunol 2007 44 : 2558 2565.
28. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991 9 : 271 296.
29. McKenna HJ, et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood 2000 95 : 3489 3497.
30. Karsunky H, Merad M, Cozzio A, Weissman IL, Manz MG. Flt3 ligand regulates dendritic cell development from Flt3+ lymphoid and myeloid-committed progenitors to Flt3+ dendritic cells in vivo. J Exp Med 2003 198 : 305 313.
31. Waskow C, et al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nat Immunol 2008 9 : 676 683.
32. Whartenby KA, et al. Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc Natl Acad Sci USA 2005 102 : 16741 16746.
33. Hochweller K, Miloud T, Striegler J, Naik S, Hammerling GJ, Garbi N. Homeostasis of dendritic cells in lymphoid organs is controlled by regulation of their precursors via a feedback loop. Blood 2009 114 : 4411 4421.
34. Kingston D, Schmid MA, Onai N, Obata-Onai A, Baumjohann D, Manz MG. The concerted action of GM-CSF and Flt3-ligand on in vivo dendritic cell homeostasis. Blood 2009 114 : 835 843.
35. Gilliet M, et al. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 2002 195 : 953 958.
36. Chen M, Huang L, Wang J. Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 2007 109 : 4360 4367.
37. Chang WL, et al. Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity. J Immunol 2007 178 : 7794 7804.
38. Watanabe N, et al. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 2004 5 : 426 434.
39. Borkowski TA, Letterio JJ, Farr AG, Udey MC. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J Exp Med 1996 184 : 2417 2422.
40. Borkowski TA, et al. Langerhans cells in the TGF beta 1 null mouse. Adv Exp Med Biol 1997 417 : 307 310.
41. Hacker C, et al. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat Immunol 2003 4 : 380 386.
42. Ito M, et al. Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. J Immunol 2006 176 : 5637 5643.
43. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 2007 8 : 191 197.
44. Riol-Blanco L, et al. Immunological synapse formation inhibits, via NF-kappaB and FOXO1, the apoptosis of dendritic cells. Nat Immunol 2009 10 : 753 760.
45. Ingulli E, Mondino A, Khoruts A, Jenkins MK. In vivo detection of dendritic cell antigen presentation to CD4(+) T cells. J Exp Med 1997 185 : 2133 2141.
46. Matsue H, et al. Dendritic cells undergo rapid apoptosis in vitro during antigen-specific interaction with CD4+ T cells. J Immunol 1999 162 : 5287 5298.
47. Borrow P, Evans CF, Oldstone MB. Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression. J Virol 1995 69 : 1059 1070.
48. Hermans IF, Ritchie DS, Yang J, Roberts JM, Ronchese F. CD8+ T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 2000 164 : 3095 3101.
49. Guarda G, et al. L-selectin-negative CCR7- effector and memory CD8+ T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007 8 : 743 752.
50. Yang J, Huck SP, McHugh RS, Hermans IF, Ronchese F. Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo. Proc Natl Acad Sci USA 2006 103 : 147 152.
51. Watchmaker PB, et al. Memory CD8+ T cells protect dendritic cells from CTL killing. J Immunol 2008 180 : 3857 3865.
52. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan MC, Liu YJ, Rabourdin-Combe C. Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997 186 : 813 823.
53. Bluestone JA, Tang Q. How do CD4+CD25+ regulatory T cells control autoimmunity? Curr Opin Immunol 2005 17 : 638 642.
54. Hori S, Takahashi T, Sakaguchi S. Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv Immunol 2003 81 : 331 371.
55. Lu LF, Rudensky A. Molecular orchestration of differentiation and function of regulatory T cells. Genes Dev 2009 23 : 1270 1282.
56. Tadokoro CE, et al. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J Exp Med 2006 203 : 505 511.
57. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004 21 : 589 601.
58. Jung S, et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002 17 : 211 220.
59. Suffner J, et al. Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol 2010 184 : 1810 1820.
60. Yamazaki S, et al. CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells. J Immunol 2008 181 : 6923 6933.
61. Sharma MD, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J Clin Invest 2007 117 : 2570 2582.
62. Belkaid Y, Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 2008 29 : 362 371.
63. Kushwah R, et al. Uptake of apoptotic DC converts immature DC into tolerogenic DC, which induce differentiation of Foxp3+ regulatory T cells. Eur J Immunol 2010 40 : 1022 1035.
64. Nopora A, Brocker T. Bcl-2 controls dendritic cell longevity in vivo. J Immunol 2002 169 : 3006 3014.
65. Gautier EL, et al. Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis. Circulation 2009 119 : 2367 2375.
66. Hayakawa Y, et al. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 2004 172 : 123 129.
67. Kang TH, et al. Enhancing dendritic cell vaccine potency by combining a BAK/BAX siRNA-mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments. Int J Cancer 2007 120 : 1696 1703.
68. Kim TW, et al. Modification of professional antigen-presenting cells with small interfering RNA in vivo to enhance cancer vaccine potency. Cancer Res 2005 65 : 309 316.
69. Peng S, et al. Vaccination with dendritic cells transfected with BAK and BAX siRNA enhances antigen-specific immune responses by prolonging dendritic cell life. Hum Gene Ther 2005 16 : 584 593.
70. Pirtskhalaishvili G, et al. Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice. J Immunol 2000 165 : 1956 1964.
71. Yu L, et al. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004 304 : 1500 1502.
72. Cho YS, et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 2009 137 : 1112 1123.
73. He S, et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha. Cell 2009 137 : 1100 1111.
74. Hitomi J, et al. Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell 2008 135 : 1311 1323.
75. Zhang DW, et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 2009 325 : 332 336.
76. Rathmell JC, Thompson CB. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 2002 109 (Suppl S97 S107.
77. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001 104 : 487 501.
78. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995 270 : 7795 7798.
79. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 1995 81 : 505 512.
80. Kischkel FC, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 1995 14 : 5579 5588.
81. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996 85 : 803 815.
82. Muzio M, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death - inducing signaling complex. Cell 1996 85 : 817 827.
83. Reed JC, et al. Comparative analysis of apoptosis and inflammation genes of mice and humans. Genome Res 2003 13 : 1376 1388.
84. Wang J, Chun HJ, Wong W, Spencer DM, Lenardo MJ. Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci USA 2001 98 : 13884 13888.
85. Kischkel FC, et al. Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 2001 276 : 46639 46646.
86. Fischer U, Stroh C, Schulze-Osthoff K. Unique and overlapping substrate specificities of caspase-8 and caspase-10. Oncogene 2006 25 : 152 159.
87. Bae S, et al. Genome-wide screening and identification of novel proteolytic cleavage targets of caspase-8 and -10 in vitro. Int J Mol Med 2008 21 : 381 386.
88. Wang J, et al. Inherited human caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 1999 98 : 47 58.
89. Chun HJ, et al. Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 2002 419 : 395 399.
90. Varfolomeev EE, et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity 1998 9 : 267 276.
91. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 1999 17 : 331 367.
92. Diehl GE, et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity 2004 21 : 877 889.
93. Funk JO, et al. Cutting edge: resistance to apoptosis and continuous proliferation of dendritic cells deficient for TNF receptor-1. J Immunol 2000 165 : 4792 4796.
94. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997 90 : 405 413.
95. Li P, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997 91 : 479 489.
96. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997 275 : 1132 1136.
97. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000 102 : 33 42.
98. Verhagen AM, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000 102 : 43 53.
99. Li LY, Luo X, Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 2001 412 : 95 99.
100. Daugas E, et al. Apoptosis-inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis. FEBS Lett 2000 476 : 118 123.
101. Levine B. Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005 120 : 159 162.
102. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008 132 : 27 42.
103. Shimizu S, et al. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004 6 : 1221 1228.
104. Schmid D, Pypaert M, Munz C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 2007 26 : 79 92.
105. Koppi TA, Tough-Bement T, Lewinsohn DM, Lynch DH, Alderson MR. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells. Eur J Immunol 1997 27 : 3161 3165.
106. Bjorck P, Banchereau J, Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. Int Immunol 1997 9 : 365 372.
107. Ashany D, Savir A, Bhardwaj N, Elkon KB. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway. J Immunol 1999 163 : 5303 5311.
108. Willems F, et al. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 2000 95 : 3478 3482.
109. Lundqvist A, Nagata T, Kiessling R, Pisa P. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L). Cancer Immunol Immunother 2002 51 : 139 144.
110. Fields ML, Sokol CL, Eaton-Bassiri A, Seo S, Madaio MP, Erikson J. Fas/Fas ligand deficiency results in altered localization of anti-double-stranded DNA B cells and dendritic cells. J Immunol 2001 167 : 2370 2378.
111. Ryan CA, Stennicke HR, Nava VE, Burch JB, Hardwick JM, Salvesen GS. Inhibitor specificity of recombinant and endogenous caspase-9. Biochem J 2002 366 : 595 601.
112. Peng SL, Moslehi J, Robert ME, Craft J. Perforin protects against autoimmunity in lupus-prone mice. J Immunol 1998 160 : 652 660.
113. Bai C, et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 2000 97 : 1230 1235.
114. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999 274 : 13733 13736.
115. Pitti RM, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998 396 : 699 703.
116. Kim S, McAuliffe WJ, Zaritskaya LS, Moore PA, Zhang L, Nardelli B. Selective induction of tumor necrosis receptor factor 6/decoy receptor 3 release by bacterial antigens in human monocytes and myeloid dendritic cells. Infect Immun 2004 72 : 89 93.
117. You RI, et al. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3). Blood 2008 111 : 1480 1488.
118. Hsu TL, et al. Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol 2002 168 : 4846 4853.
119. Chattergoon MA, et al. DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo. Mol Ther 2008 16 : 419 426.
120. Semnani RT, et al. Induction of TRAIL- and TNF-alpha-dependent apoptosis in human monocyte-derived dendritic cells by microfilariae of Brugia malayi. J Immunol 2008 181 : 7081 7089.
121. Kriehuber E, et al. Balance between NF-kappaB and JNK/AP-1 activity controls dendritic cell life and death. Blood 2005 106 : 175 183.
122. Wong BR, et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997 186 : 2075 2080.
123. Castera L, et al. Apoptosis-related mitochondrial dysfunction defines human monocyte-derived dendritic cells with impaired immuno-stimulatory capacities. J Cell Mol Med 2009 13 : 1321 1335.
124. Cremer I, et al. Long-lived immature dendritic cells mediated by TRANCE-RANK interaction. Blood 2002 100 : 3646 3655.
125. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002 16 : 257 270.
126. Chino T, Draves KE, Clark EA. Regulation of dendritic cell survival and cytokine production by osteoprotegerin. J Leukoc Biol 2009 86 : 933 940.
127. Izawa T, Ishimaru N, Moriyama K, Kohashi M, Arakaki R, Hayashi Y. Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance. Blood 2007 110 : 242 250.
128. Adams JM, et al. Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb Symp Quant Biol 1999 64 : 351 358.
129. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999 13 : 1899 1911.
130. Strasser A. The role of BH3-only proteins in the immune system. Nat Rev Immunol 2005 5 : 189 200.
131. Puthalakath H, Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 2002 9 : 505 512.
132. Chen M, Sandoval H, Wang J. Selective mitochondrial autophagy during erythroid maturation. Autophagy 2008 4 : 926 928.
133. Sandoval H, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008 454 : 232 235.
134. Bouillet P, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999 286 : 1735 1738.
135. Bouillet P, et al. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002 415 : 922 926.
136. Enders A, Bouillet P, Puthalakath H, Xu Y, Tarlinton DM, Strasser A. Loss of the pro-apoptotic BH3-only Bcl-2 family member Bim inhibits BCR stimulation-induced apoptosis and deletion of autoreactive B cells. J Exp Med 2003 198 : 1119 1126.
137. Lu J, Quearry B, Harada H. p38-MAP kinase activation followed by BIM induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 2006 580 : 3539 3544.
138. Sunters A, et al. FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. J Biol Chem 2003 278 : 49795 49805.
139. Gilley J, Coffer PJ, Ham J. FOXO transcription factors directly activate bim gene expression and promote apoptosis in sympathetic neurons. J Cell Biol 2003 162 : 613 622.
140. Lanzavecchia A, Sallusto F. Regulation of T cell immunity by dendritic cells. Cell 2001 106 : 263 266.
141. Blander JM, Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006 440 : 808 812.
142. Cisse B, et al. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008 135 : 37 48.
143. Zanoni I, et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFAT activation. Nature 2009 460 : 264 268.
144. Escribano C, Delgado-Martin C, Rodriguez-Fernandez JL. CCR7-dependent stimulation of survival in dendritic cells involves inhibition of GSK3beta. J Immunol 2009 183 : 6282 6295.
145. Yen JH, Ganea D. Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation. Blood 2009 114 : 1344 1354.
146. Marrack P, Kappler J. Positive selection of thymocytes bearing alpha beta T cell receptors. Curr Opin Immunol 1997 9 : 250 255.
147. von Boehmer H, Swat W, Kisielow P. Positive selection of immature alpha beta T cells. Immunol Rev 1993 135 : 67 79.
148. Nossal GJ. Negative selection of lymphocytes. Cell 1994 76 : 229 239.
149. Werlen G, Hausmann B, Naeher D, Palmer E. Signaling life and death in the thymus: timing is everything. Science 2003 299 : 1859 1863.
150. Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity 2009 30 : 616 625.
151. Shevach EM. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 2009 30 : 636 645.
152. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995 16 : 39 43.
153. Adachi M, Watanabe-Fukunaga R, Nagata S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 1993 90 : 1756 1760.
154. Takahashi T, et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994 76 : 969 976.
155. Rieux-Laucat F, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995 268 : 1347 1349.
156. Fisher GH, et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995 81 : 935 946.
157. Wu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 1996 98 : 1107 1113.
158. Bidere N, Su HC, Lenardo MJ. Genetic disorders of programmed cell death in the immune system. Annu Rev Immunol 2006 24 : 321 352.
159. Singer GG, Abbas AK. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994 1 : 365 371.
160. Smith KG, Strasser A, Vaux DL. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J 1996 15 : 5167 5176.
161. Wu Z, et al. Viral FLIP impairs survival of activated T cells and generation of CD8+ T cell memory. J Immunol 2004 172 : 6313 6323.
162. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. Immunity 1998 8 : 439 449.
163. Doerfler P, Forbush KA, Perlmutter RM. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J Immunol 2000 164 : 4071 4079.
164. Izquierdo M, et al. Blocked negative selection of developing T cells in mice expressing the baculovirus p35 caspase inhibitor. EMBO J 1999 18 : 156 166.
165. Newton K, Harris AW, Bath ML, Smith KG, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J 1998 17 : 706 718.
166. Zornig M, Hueber AO, Evan G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice. Curr Biol 1998 8 : 467 470.
167. Watanabe D, Suda T, Hashimoto H, Nagata S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J 1995 14 : 12 18.
168. Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 2004 199 : 1355 1365.
169. Gollob KJ, Palmer E. Divergent viral superantigens delete V beta 5+ T lymphocytes. Proc Natl Acad Sci USA 1992 89 : 5138 5141.
170. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002 3 : 932 939.
171. Suda T, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995 154 : 3806 3813.
172. Wang J, Lenardo MJ. Essential lymphocyte function associated 1 (LFA-1): intercellular adhesion molecule interactions for T cell-mediated B cell apoptosis by Fas/APO-1/CD95. J Exp Med 1997 186 : 1171 1176.
173. Lenardo MJ. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991 353 : 858 861.
174. Zheng L, Trageser CL, Willerford DM, Lenardo MJ. T cell growth cytokines cause the superinduction of molecules mediating antigen-induced T lymphocyte death. J Immunol 1998 160 : 763 769.
175. Lindsten T, et al. The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. Mol Cell 2000 6 : 1389 1399.
176. Wei MC, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 2001 292 : 727 730.
177. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994 179 : 1127 1135.
178. Wilson NS, El-Sukkari D, Villadangos JA. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 2004 103 : 2187 2195.
179. Nurieva RI, et al. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008 29 : 138 149.